<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-17419" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part indexed="no" book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Alveolar Proteinosis (Archived)</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Mlika</surname>
            <given-names>Mouna</given-names>
          </name>
          <aff>University of Medicine of Tunis</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Basit</surname>
            <given-names>Hajira</given-names>
          </name>
          <aff>Brookdale University</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Kaul</surname>
            <given-names>Pratibha</given-names>
          </name>
          <aff>Upstate Medical University</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Mouna Mlika declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Hajira Basit declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Pratibha Kaul declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>10</day>
          <month>4</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-17419.s1" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Pulmonary alveolar proteinosis is a rare disease characterized by an accumulation of a lipoproteinaceous material within the alveoli. It can be idiopathic or secondary.&#x000a0;It is also known as pulmonary alveolar phospholipoproteinosis and alveolar lipoproteinosis.<xref ref-type="bibr" rid="article-17419.r1">[1]</xref></p>
      </sec>
      <sec id="article-17419.s2" sec-type="Etiology">
        <title>Etiology</title>
        <p>Pulmonary alveolar proteinosis may be idiopathic or secondary. Secondary cases may accompany the following disorders:</p>
        <list list-type="bullet">
          <list-item>
            <p>Infections&#x000a0;including bacteria (<italic toggle="yes">Nocardia, </italic>mycobacteria), fungi, viruses, or <italic toggle="yes">Pneumocystis jiroveci</italic></p>
          </list-item>
          <list-item>
            <p>Neoplasms including lymphomas and leukemias</p>
          </list-item>
          <list-item>
            <p>Inorganic dust exposure including silicosis and aluminum</p>
          </list-item>
          <list-item>
            <p>Immunodeficiencies such as HIV infection, lung transplantation, and IgA deficiency</p>
          </list-item>
        </list>
        <p>Other conditions such as surfactant deficiency and Fanconi's anemia also have associations with the disorder.</p>
      </sec>
      <sec id="article-17419.s3" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>The incidence and prevalence of alveolar proteinosis are not known.&#x000a0;Pulmonary alveolar proteinosis is a rare disease mainly observed in males, with a sex ratio of 2:1. Estimates of the mean age of these patients run between 30 and 50 years with exceptional pediatric cases.<xref ref-type="bibr" rid="article-17419.r2">[2]</xref> A small number of case reports in infants and children exist. Many patients are former or current smokers.</p>
      </sec>
      <sec id="article-17419.s4" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>The pathogenesis of this disease continues to be unclear, but many theories have been proffered in the literature, including an impairment in the ability of macrophages to clear secretions or an overproduction of surfactant dealing with a deficient clearance activity of macrophages.</p>
        <p>The macrophages themselves are a potential contributing factor in the formation of the amorphous material upon dying. The theory of impaired macrophage function is sustained by the association of this disease to immunodeficiency diseases that cause dysfunction of macrophages. Moreover, reports of the presence of antibodies of immunoglobulin isotype G against granulocyte-macrophage-colony-stimulating factor (GM-CSF) in pulmonary proteinosis also exist.<xref ref-type="bibr" rid="article-17419.r2">[2]</xref><xref ref-type="bibr" rid="article-17419.r3">[3]</xref></p>
      </sec>
      <sec id="article-17419.s5" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>The diagnosis of alveolar proteinosis may be made&#x000a0;based on the bronchoalveolar fluid findings but is frequently made based on tissue samples including open or transbronchial biopsy.</p>
        <p>Bronchoalveolar lavage (BAL) fluid is characteristic when it has a milky appearance. The presence of alveolar macrophages engorged with Periodic Acid Schiff (PAS) positive material, and acellular eosinophilic bodies in a background of eosinophilic granules are key features. The bronchoalveolar lavage formula characteristically presents with a decrease in the number of alveolar macrophages and a slight increase in T lymphocytes&#x000a0;(with a tendency toward a high CD4/CD8 ratio).&#x000a0;Elevated levels of several tumor markers (carcinoembryonic antigen (CEA), and carbohydrate antigens sialyl&#x000a0;Lewis (CA19-9) have been found in bronchoalveolar lavage fluid form in&#x000a0;some&#x000a0;patients with alveolar proteinosis. It is possible that these markers may reflect disease activity without a real consensus. Serum or BAL KL-6 has proven useful for the diagnosis of alveolar proteinosis and the estimation of its activity.</p>
        <p>Gross features consist of a yellow-tan discolorated parenchyma. The architecture of the lung appears preserved, and the process appears to&#x000a0;fill the alveolar spaces. The abnormality primarily affects the right and appears to fill the alveolar spaces.</p>
        <p>In tissue specimens, the histologic hallmark consists of an intra-alveolar accumulation of a granular eosinophilic and amorphous material with diffuse and rarely patchy lesions. Within this material, rounded empty spaces, cholesterol clefts, and small dense globular eosinophilic material are distinctive features of the diagnosis. Interstitial fibrosis or inflammation is commonly absent. If observed, the association to an infection&#x000a0;or a neoplasm has to be suspected by the pathologist. In case of an association to silicosis, the polarization microscopy may show birefringent needle-like particles. In long-standing cases, observable tissue changes may include interstitial fibrosis.<xref ref-type="bibr" rid="article-17419.r1">[1]</xref><xref ref-type="bibr" rid="article-17419.r4">[4]</xref></p>
        <p>With electron microscopy, the characteristic features consist of&#x000a0;multilamellar structures of trilaminar membranes separated by amorphous material. Electron-dense&#x000a0;bodies and membranous vesicles are often found at the center of the multilamellar structures. Even though these features can be helpful, electron microscopy is not routinely done.</p>
      </sec>
      <sec id="article-17419.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Pulmonary proteinosis is asymptomatic in one-third of the patients. In symptomatic patients, symptoms are non-specific consisting mainly of&#x000a0;cough, dyspnea, fatigue, weight loss, hemoptysis, and chest pain. In very rare cases, patients may report an expectoration of 'chunky' gelatinous material. Physical examination is often normal. Auscultation of crackles may be a feature on chest examination, but lung auscultation is often normal because of the absence of gas movement due to the complete filling of distal airspaces.<xref ref-type="bibr" rid="article-17419.r5">[5]</xref><xref ref-type="bibr" rid="article-17419.r6">[6]</xref></p>
      </sec>
      <sec id="article-17419.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>The characteristic findings on high resolution computed tomography consist of bilateral ground-glass opacities often associated with interlobular septal thickening with a characteristic feature of 'crazy paving.' In less typical cases, radiologic findings consist of bilateral and symmetrical areas of airspace consolidation or ground-glass opacities. In patients with less severe disease, the radiologic features may consist of hazy areas of ground-glass opacities rather than consolidation. The abnormalities tend to&#x000a0;involve mainly the perihilar regions and lower lobes.<xref ref-type="bibr" rid="article-17419.r7">[7]</xref></p>
      </sec>
      <sec id="article-17419.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>No immediate treatment is&#x000a0;necessary&#x000a0;in some cases&#x000a0;because of the potential for spontaneous remission. In the majority of the cases, the treatment basis is therapeutic whole-lung lavage via a double-lumen endotracheal tube.<xref ref-type="bibr" rid="article-17419.r6">[6]</xref><xref ref-type="bibr" rid="article-17419.r7">[7]</xref></p>
      </sec>
      <sec id="article-17419.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The major differential diagnoses consist of:</p>
        <list list-type="bullet">
          <list-item>
            <p>Pulmonary edema - characterized by edematous material that lacks coarse granules, cholesterol clefts, and foamy macrophages.</p>
          </list-item>
          <list-item>
            <p><italic toggle="yes">Pneumocystis&#x000a0;jiroveci</italic> pneumonia - consisting of intra-alveolar eosinophilic exudate with 'bubbles' corresponding to cysts of organisms that can be highlighted&#x000a0;using Grocott special stain.</p>
          </list-item>
          <list-item>
            <p>Alveolar mucinosis - intra-alveolar accumulation of mucin are potentially observable in association with mucinous adenocarcinomas or bronchiectasis or honeycomb fibrosis.<xref ref-type="bibr" rid="article-17419.r1">[1]</xref><xref ref-type="bibr" rid="article-17419.r8">[8]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-17419.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The prognosis of alveolar proteinosis is generally good as many patients are asymptomatic. Approximately 30% to 40% of&#x000a0;symptomatic patients require only one lavage. Other patients may require repeat lung lavages at intervals of 6 to 12 months.</p>
      </sec>
      <sec id="article-17419.s11" sec-type="Complications">
        <title>Complications</title>
        <p>Complications have been rarely reported and are mainly a result of treatment with whole-lung lavage. These include malpositioning of the endotracheal tube, saline spillover into the unlavaged ventilated lung, and hydropneumothorax.<xref ref-type="bibr" rid="article-17419.r9">[9]</xref></p>
      </sec>
      <sec id="article-17419.s12" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Patients with pulmonary alveolar proteinosis should be educated that their symptoms will improve significantly with whole-lung lavage, but relapses may occur. Repeat lavages are frequently is needed&#x000a0;so they will require regular follow-up with their pulmonologist. Patients&#x000a0;with secondary&#x000a0;alveolar proteinosis related to the inhalation of inorganic dusts or insecticides should be educated to avoid repeat exposure.</p>
      </sec>
      <sec id="article-17419.s13" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Alveolar lipoproteinosis is a rare disease with non-specific diagnostic features. An interprofessional approach including pathologists and pulmonologists is mandatory to assess the diagnosis competently. The pulmonologist has to suspect the diagnosis when performing a bronchoalveolar lavage on a patient explored for an interstitial disease. The gross appearance of the liquid can be suggestive of the diagnosis. Additionally, the pathologist can make the diagnosis on liquid or tissue samples. In the bronchoalveolar lavage, the granular material with the presence of eosinophilic bodies and granules are key features. In tissue samples, the presence of&#x000a0;alveoli filled with PAS-positive eosinophilic material is a hallmark. The presence of fibrosis or inflammatory infiltrates&#x000a0;should highlight the possibility of an associated disease.</p>
      </sec>
      <sec id="article-17419.s14">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=17419&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=17419">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/17419/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=17419">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-17419.s15">
        <title>References</title>
        <ref id="article-17419.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mlika</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Triki</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kwas</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Braham</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Ghedira</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Mezni</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>When the bronchoalveolar lavage makes the diagnosis of interstitial pneumonia.</article-title>
            <source>Clin Respir J</source>
            <year>2018</year>
            <month>Jan</month>
            <volume>12</volume>
            <issue>1</issue>
            <fpage>352</fpage>
            <page-range>352-353</page-range>
            <pub-id pub-id-type="pmid">26895556</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17419.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hirakawa</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Taniwaki</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Yamasaki</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Imanaka</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Hattori</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Secondary pulmonary alveolar proteinosis in acute myeloid leukemia.</article-title>
            <source>QJM</source>
            <year>2019</year>
            <month>Apr</month>
            <day>01</day>
            <volume>112</volume>
            <issue>4</issue>
            <fpage>293</fpage>
            <page-range>293-294</page-range>
            <pub-id pub-id-type="pmid">30295888</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17419.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sirin Kose</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Asilsoy</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Uzuner</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Karaman</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Ozer</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Anal</surname>
                <given-names>O</given-names>
              </name>
            </person-group>
            <article-title>Pulmonary Alveolar Proteinosis in Hereditary and Autoimmune Forms With 2 Cases.</article-title>
            <source>Pediatr Emerg Care</source>
            <year>2020</year>
            <month>Aug</month>
            <volume>36</volume>
            <issue>8</issue>
            <fpage>e470</fpage>
            <page-range>e470-e472</page-range>
            <pub-id pub-id-type="pmid">30113436</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17419.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ronsmans</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Nemery</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>The presence of autoimmune antibodies in pulmonary alveolar proteinosis does not necessarily imply idiopathic disease.</article-title>
            <source>Lancet Respir Med</source>
            <year>2018</year>
            <month>Sep</month>
            <volume>6</volume>
            <issue>9</issue>
            <fpage>e48</fpage>
            <pub-id pub-id-type="pmid">30057290</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17419.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rawat</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mathew</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Pandiarajan</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Jindal</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Suri</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Gupta</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Goel</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Karim</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Saikia</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Minz</surname>
                <given-names>RW</given-names>
              </name>
              <name>
                <surname>Imai</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Nonoyama</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ohara</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Giliani</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Notarangelo</surname>
                <given-names>LD</given-names>
              </name>
              <name>
                <surname>Chan</surname>
                <given-names>KW</given-names>
              </name>
              <name>
                <surname>Lau</surname>
                <given-names>YL</given-names>
              </name>
              <name>
                <surname>Singh</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Clinical and molecular features of X-linked hyper IgM syndrome - An experience from North India.</article-title>
            <source>Clin Immunol</source>
            <year>2018</year>
            <month>Oct</month>
            <volume>195</volume>
            <fpage>59</fpage>
            <page-range>59-66</page-range>
            <pub-id pub-id-type="pmid">30053428</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17419.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ikeda</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sekine</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Baba</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Katano</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Yamakawa</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Oda</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Iwasawa</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Matsumura</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Takemura</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Ogura</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Secondary pulmonary alveolar proteinosis predominant in the transplanted lung in patients with idiopathic interstitial pneumonia: an autopsy case.</article-title>
            <source>J Thorac Dis</source>
            <year>2018</year>
            <month>May</month>
            <volume>10</volume>
            <issue>5</issue>
            <fpage>E351</fpage>
            <page-range>E351-E354</page-range>
            <pub-id pub-id-type="pmid">29997992</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17419.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ramachandran</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Chaudhury</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Devaraj</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Maheshwari</surname>
                <given-names>KU</given-names>
              </name>
              <name>
                <surname>D'Souza</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Monitoring whole-lung lavage using lung ultrasound: The changing phases of the lung.</article-title>
            <source>Lung India</source>
            <year>2018</year>
            <season>Jul-Aug</season>
            <volume>35</volume>
            <issue>4</issue>
            <fpage>350</fpage>
            <page-range>350-353</page-range>
            <pub-id pub-id-type="pmid">29970780</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17419.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Athayde</surname>
                <given-names>RAB</given-names>
              </name>
              <name>
                <surname>Arimura</surname>
                <given-names>FE</given-names>
              </name>
              <name>
                <surname>Kairalla</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Carvalho</surname>
                <given-names>CRR</given-names>
              </name>
              <name>
                <surname>Baldi</surname>
                <given-names>BG</given-names>
              </name>
            </person-group>
            <article-title>Characterization and outcomes of pulmonary alveolar proteinosis in Brazil: a case series.</article-title>
            <source>J Bras Pneumol</source>
            <year>2018</year>
            <season>May-Jun</season>
            <volume>44</volume>
            <issue>3</issue>
            <fpage>231</fpage>
            <page-range>231-236</page-range>
            <pub-id pub-id-type="pmid">30043890</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17419.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Skoczynski</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Wyskida</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Rzepka-Wrona</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Wyskida</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Uszok-Gawel</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Bartocha</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Krzych</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Pierzchala</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Barczyk</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Novel method of noninvasive ventilation supported therapeutic lavage in pulmonary alveolar proteinosis proves to relieve dyspnea, normalize pulmonary function test results and recover exercise capacity: a short communication.</article-title>
            <source>J Thorac Dis</source>
            <year>2018</year>
            <month>Apr</month>
            <volume>10</volume>
            <issue>4</issue>
            <fpage>2467</fpage>
            <page-range>2467-2473</page-range>
            <pub-id pub-id-type="pmid">29850154</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
